4//SEC Filing
Conatus Pharmaceuticals Inc. 4
Accession 0001209191-17-006696
CIK 0001383701operating
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:22 PM ET
Size
5.8 KB
Accession
0001209191-17-006696
Insider Transaction Report
Form 4
Hagerty David T
EVP, Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2017-01-26+100,625→ 100,625 totalExercise: $4.21Exp: 2027-01-25→ Common Stock (100,625 underlying)
Footnotes (1)
- [F1]The option was granted on January 26, 2017. 25% of the total number of shares of common stock subject to the option will vest on January 26, 2018, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Conatus Pharmaceuticals Inc.
CIK 0001383701
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001383701
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:22 PM ET
- Size
- 5.8 KB